News

Pharmabiz54m
Goa DFDA’s Observer status with US FDA strengthens pharma sector in Goa: Shweta Dessai
Goa DFDA’s Observer status with US FDA strengthens pharma sector in Goa: Shweta Dessai: Shardul Nautiyal, Mumbai Thursday, August 7, 2025, 08:00 Hrs [IST] Goa’s pharmaceutical ...
Pharmabiz54m
Goa PMRU conducts district level awareness programme in North Goa to ensure drug pricing compliance
Goa PMRU conducts district level awareness programme in North Goa to ensure drug pricing compliance: Shardul Nautiyal, Mumbai Thursday, August 7, 2025, 08:00 Hrs [IST] The Goa Sta ...
Pharmabiz54m
India's PLI scheme transforms pharma industry from policy to practice: Vikram Aditya Sehgal
India's PLI scheme transforms pharma industry from policy to practice: Vikram Aditya Sehgal: Nandita Vijayasimha, Bengaluru Thursday, August 7, 2025, 08:00 Hrs [IST] India's produ ...
Pharmabiz54m
Mohan Babu University in Tirupati develops low-cost hearing aid
Mohan Babu University in Tirupati develops low-cost hearing aid: Nandita Vijayasimha, Bengaluru Thursday, August 7, 2025, 08:00 Hrs [IST] The Mohan Babu University (MBU), Tirupati ...
Pharmabiz54m
Pondicherry govt to issue official order for Karasur Pharma Park soon
The Government of Union Territory of Pondicherry is expected to issue a Government Order (GO) this month to formally establish the Karasur Pharma Park Project. According to Dr E Anandakrishnan, the ...
Pharmabiz18h
Innovent Biologics receives US FDA clearance to initiate phase 1 clinical trial of novel oral GLP-1R agonist, IBI3032
Innovent Biologics receives US FDA clearance to initiate phase 1 clinical trial of novel oral GLP-1R agonist, IBI3032: San Francisco Wednesday, August 6, 2025, 14:00 Hrs [IST] Inn ...
Pharmabiz18h
Medistep Healthcare's IPO to open on August 8; Issue price fixed at Rs. 43 per share
Medistep Healthcare's IPO to open on August 8; Issue price fixed at Rs. 43 per share: Our Bureau, Mumbai Wednesday, August 6, 2025, 14:15 Hrs [IST] Medistep Healthcare Limited, a ...
Pharmabiz15h
US FDA clears CASI Pharma’s IND application for CID-103 in renal allograft antibody-mediated rejection
US FDA clears CASI Pharma’s IND application for CID-103 in renal allograft antibody-mediated rejection: San Francisco, California Wednesday, August 6, 2025, 17:00 Hrs [IST] CASI ...
Pharmabiz15h
Servier India receives positive recommendation from SEC to import & market vorasidenib tablets in India to treat grade 2 IDH-mutant diffuse glioma
Servier India receives positive recommendation from SEC to import & market vorasidenib tablets in India to treat grade 2 IDH-mutant diffuse glioma: Our Bureau, Mumbai Wednesday, A ...
Pharmabiz16h
Axplora announces Euro 6.5 million investment at Vizag site and FDA inspection success across Indian operations
Axplora announces Euro 6.5 million investment at Vizag site and FDA inspection success across Indian operations: Our Bureau, Bengaluru Wednesday, August 6, 2025, 16:15 Hrs [IST] A ...
Pharmabiz16h
Vasa Denticity acquires 51% stake in IDS Denmed to create India’s largest integrated dental supply network
Vasa Denticity acquires 51% stake in IDS Denmed to create India’s largest integrated dental supply network: Our Bureau, Bengaluru Wednesday, August 6, 2025, 16:40 Hrs [IST] Vasa ...
Pharmabiz17h
US FDA clears Hemispherian’s IND application for first-in-class glioblastoma therapeutic, GLIX1
US FDA clears Hemispherian’s IND application for first-in-class glioblastoma therapeutic, GLIX1: Oslo, Norway Wednesday, August 6, 2025, 15:00 Hrs [IST] Hemispherian AS, a pione ...